Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BYPLOS One

Prevalence of human papillomavirus and HPV vaccination among cisgender bisexual women: Protocol for a systematic review and meta-analysis

4 affiliations
  1. 1Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
  2. 2School of Public Health, University of Washington, Seattle, Washington, United States of America.
  3. 3Department of Health Systems and Population Health, University of Washington, Seattle, Washington, United States of America.
  4. 4Department of Anthropology, University of Washington, Seattle, Washington, United States of America.

Abstract

Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and a primary cause of cervical cancer. Although cervical cancer is largely preventable through HPV vaccination, vaccine coverage remains suboptimal. Research on HPV prevalence and vaccination among cisgender bisexual women is limited and inconsistent. This may be partly due to variation in how bisexuality is defined. Bisexuality may be operationalized based on sexual identity (e.g., self-identification as bisexual) or sexual behavior (e.g., sexual contact with more than one sex or gender), and these differing definitions may capture distinct populations and yield divergent health findings. This paper proposes a protocol for a systematic review and meta-analysis to examine whether reported HPV prevalence and vaccination rates among cisgender bisexual women differ based on whether bisexuality is defined by identity or behavior. The protocol is registered in PROSPERO (CRD420251252015) and follows PRISMA-P guidelines. Random-effects meta-analyses will estimate pooled HPV prevalence and vaccination rates by definition type. Findings will clarify how operational definitions shape observed HPV-related outcomes and inform tailored cervical cancer prevention strategies for cisgender bisexual women.

Related

  1. Enablers and barriers to human papillomavirus vaccination implementation among key stakeholders in Ethiopia: A qualitative study
    Kibir Temesgen Assefa, Abebaw Gebeyehu Worku, Achenef Asmamaw Muche +3
    PLOS OnePeer-reviewedCC BYFull textImmunologyMicrobiologyPLOSEurope PMCPMC
  2. Prevalence and distribution of high-risk human papillomavirus genotypes among women living with HIV in Nigeria
    Ijeoma M Ifeorah, Jonadab Chinwendu, Stanley C Eneh +15
    PLOS OnePeer-reviewedCC BYFull textImmunologyMicrobiologyPLOSEurope PMCPMC
  3. Prevalence of high-risk human papillomavirus genotypes and associated factors among HIV-infected women in a reproductive age group attending antiretroviral therapy in Nekemte town, Oromia, Ethiopia
    Rundase Gebeyehu, Seifu Gizaw, Desta Amensisa +4
    PLOS OnePeer-reviewedCC BY 4.0Full textImmunologyMicrobiologyPLOS
  4. Effects of Feline Herpesvirus Type 1 Vaccination on Clinical Disease, Viral Shedding, and Post-Vaccination Reactions: A Systematic Review and Exploratory Meta-Analysis.
    Zhen Lei, Chang Liu, Zhihua Yang +3
    VirusesPeer-reviewedCC BYFull textZoology & animal behaviourEurope PMC
  5. Enrollment in participatory surveillance programs and influenza vaccination uptake: A systematic review protocol
    Oluchi Joan Kanma-Okafor, Priyanka Ravi, Maiya G. Block Ngaybe +7
    PLOS OnePeer-reviewedCC BY 4.0Full textImmunologyEpidemiology & public healthPLOS
BibTeX
@article{lawley2026prevalence,
  title = {{Prevalence of human papillomavirus and HPV vaccination among cisgender bisexual women: Protocol for a systematic review and meta-analysis}},
  author = {Kendall A Lawley and Karthikeya Kusuma and Stephanie A Farquhar and Steven M Goodreau and Rachel L Winer},
  journal = {PLOS One},
  year = {2026},
  month = nov,
  doi = {10.1371/journal.pone.0360427},
  url = {https://doi.org/10.1371/journal.pone.0360427},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Prevalence of human papillomavirus and HPV vaccination among cisgender bisexual women: Protocol for a systematic review and meta-analysis
AU  - Kendall A Lawley
AU  - Karthikeya Kusuma
AU  - Stephanie A Farquhar
AU  - Steven M Goodreau
AU  - Rachel L Winer
PY  - 2026
DA  - 2026/11/10
JO  - PLOS One
DO  - 10.1371/journal.pone.0360427
UR  - https://doi.org/10.1371/journal.pone.0360427
AB  - Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and a primary cause of cervical cancer. Although cervical cancer is largely preventable through HPV vaccination, vaccine coverage remains suboptimal. Research on HPV prevalence and vaccination among cisgender bisexual women is limited and inconsistent. This may be partly due to variation in how bisexuality is defined. Bisexuality may be operationalized based on sexual identity (e.g., self-identification as bisexual) or sexual behavior (e.g., sexual contact with more than one sex or gender), and these differing definitions may capture distinct populations and yield divergent health findings. This paper proposes a protocol for a systematic review and meta-analysis to examine whether reported HPV prevalence and vaccination rates among cisgender bisexual women differ based on whether bisexuality is defined by identity or behavior. The protocol is registered in PROSPERO (CRD420251252015) and follows PRISMA-P guidelines. Random-effects meta-analyses will estimate pooled HPV prevalence and vaccination rates by definition type. Findings will clarify how operational definitions shape observed HPV-related outcomes and inform tailored cervical cancer prevention strategies for cisgender bisexual women.
SN  - 1932-6203
ER  -